Development of In Vitro Diagnostic Reagents, Fine Polymers, and Adhesive Polymers

「Sales of adhesives remained strong. Sales of toner-related materials, including resin-based charge-control agents and external additives, remained firm. In the medical materials field, overseas sales of diabetes diagnostic reagents remained firm.」

「Sales of new adhesive products remained firm. In the medical materials field, overseas sales of diabetes diagnostic products remained firm. As a result, revenue was ¥4,899 million, up 6.7% year on year, and operating profit was ¥388 million, up 69.5%.」

「Sales of adhesives for new products remained firm. In the medical materials field, overseas sales of diabetes diagnostic reagents remained firm.」

「Sales in the adhesives field remained strong, supported by the launch of new products and a review of the product mix. In the medical materials field, sales of the core diabetes diagnostic reagents increased year on year, despite difficulties in overseas markets. As a result, revenue was ¥2,458 million, up 6.7% year on year, and operating profit was ¥205 million, up 232.5%.」

「Results were strong in areas including fine materials, adhesives, resins and charge control agents. In the medical materials field, overseas sales of the core diabetes diagnostic reagents remained firm. As a result, revenue was ¥4,592 million, up 10.5% year on year, and operating profit was ¥229 million, compared with an operating loss of ¥49 million in the previous fiscal year.」

「In addition to toner resins and charge control agents, sales of adhesives for electronic components and newly launched UV-peelable adhesives remained strong. In the medical materials field, diabetes diagnostic products maintained sales at approximately the previous year's level, while sales of raw-material latex in China remained sluggish. As a result, revenue was ¥2,304 million, up 10.3% year on year, and operating profit was ¥62 million, up 271.2%.」

「Sales of toner-related materials remained sluggish due to the downturn in the copier market. In adhesives, sales of wallpaper adhesives remained strong. In the medical materials field, sales of reagent raw materials in China remained sluggish, while sales of raw materials for the core diabetes diagnostic products remained firm, mainly in India and Brazil. As a result, revenue was ¥4,157 million, up 1.9% year on year, and the company posted an operating loss of ¥49 million, compared with an operating loss of ¥1 million in the previous fiscal year.」

「In the Chemicals segment, which handles toner-related materials, resin bases such as ACRYBASE, and medical materials, sales of toner-related materials remained sluggish despite signs of recovery in overseas sales. Sales of adhesives remained strong, led by wallpaper adhesives. In the medical materials field, sales of the core diabetes diagnostic products remained firm, mainly overseas. As a result, revenue was ¥3,176 million, up 0.8% year on year, and operating profit was ¥7 million, down 73.9%.」

「Sales of toner-related materials remained sluggish. Meanwhile, sales of general-purpose adhesives, including wallpaper adhesives, remained strong. In the medical materials field, sales of the core diabetes diagnostic products remained firm, mainly overseas. As a result, revenue was ¥2,089 million, down 3.7% year on year, and operating profit was ¥17 million, down 54.2%.」

「The pressure-sensitive and adhesive resin base business performed well as the rollout of wallpaper adhesives and block polymers using new polymerization technology progressed. In medical materials, expansion into newly developed markets, mainly in India, progressed well, although business for the main diabetes testing reagents remained weak in China.」

「Toner resin sales remained firm in the first half but were weak in the second half due to the impact of customers’ inventory adjustments and renovations to customers’ manufacturing lines. Meanwhile, sales of wallpaper adhesives remained strong. In the medical materials field, overseas reagent sales remained firm. As a result, sales were ¥4,078 million, up 0.6% year on year, and the operating loss was ¥121 million, compared with operating profit of ¥168 million in the previous fiscal year.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, toner resin sales remained firm in the first half but increased only slightly in the second half due to the impact of customers’ inventory adjustments. Sales of wallpaper adhesives remained strong. In the medical materials field, overseas sales of reagents remained firm. As a result, sales were ¥3,150 million, up 4.8% year on year, but the operating loss was ¥55 million, compared with operating profit of ¥139 million in the same quarter of the previous year.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, sales of toner resins for overseas markets and wallpaper adhesives remained firm. In the medical materials field, sales of rheumatoid arthritis diagnostic reagents also remained strong. As a result, sales were ¥2,170 million, up 8.4% year on year, but the operating loss was ¥25 million, compared with operating profit of ¥116 million in the same quarter of the previous year.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, demand for toner resin sales, mainly for overseas markets, remained firm. Sales of pressure-sensitive adhesives for wallpaper and industrial applications also remained firm. As a result, sales were ¥1,126 million, up 6.5% year on year, and operating profit was ¥10 million, down 88.4%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, demand for toner resins remained firm. In the pressure-sensitive adhesives field, demand remained firm, partly due to the contribution to sales from resin for pressure-sensitive adhesives using a newly developed triblock polymer. In the medical materials field, overseas sales of raw materials for the main diabetes diagnostic reagents were uneven, and demand remained weak. As a result, sales were ¥3,006 million, up 20.8% year on year, and operating profit was ¥139 million, up 62.0%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, the toner market was recovering from the previous period’s decline, and demand in the electronics market, including PCs, remained at a high level. In the pressure-sensitive adhesives field, new materials for electronics, including triblock polymers, and wallpaper adhesives contributed to higher sales. In the medical materials field, expansion in India and Vietnam produced results, but expansion in China and the EU remained stalled and business was weak. As a result, sales were ¥2,001 million, up 25.1% year on year, and operating profit was ¥116 million, up 438.9%.」

「Toner demand, which had declined as telework became widespread globally, showed signs of recovery, and demand for toner resins remained firm. In addition, resin for pressure-sensitive adhesives using a newly developed block polymer was launched and contributed to sales. As a result, sales were ¥1,057 million, up 17.8% year on year, and operating profit was ¥88 million, up 379.9%.」

「In the Chemical Products segment, which handles Functional Materials sold under the “Acrybase” brand, toner resins and medical materials, toner resin sales remained weak as telework became widespread and offices moved toward paperless operations. In the medical materials field, demand for the main diagnostic reagents also remained weak due to a decline in the number of tests and other factors related to COVID-19. As a result, sales were ¥3,424 million, down 13.5% year on year, and operating profit was ¥158 million, down 50.0%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, toner resin sales remained weak as office demand declined amid the global shift to telework. As a result, sales were ¥2,488 million, down 18.0% year on year, and operating profit was ¥86 million, down 67.3%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, demand for toner resins remained weak due to the decline in printed materials associated with the shift to telework. Overseas demand for diabetes diagnostic reagents, the main product in the medical materials field, also remained weak due to the impact of COVID-19. As a result, sales were ¥1,599 million, down 20.1% year on year, and operating profit was ¥22 million, down 88.2%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, overseas toner resin sales remained firm, while domestic toner resin sales remained weak. Sales in China of diabetes diagnostic reagents, the main product in the medical materials field, also remained weak. As a result, sales were ¥898 million, down 10.0% year on year, and operating profit was ¥18 million, down 82.2%.」

「In the Chemical Products segment, which handles Functional Materials sold under the “Acrybase” brand, toner resins and medical materials, demand for wallpaper adhesives remained firm in the Functional Materials field. In the Chemical Products field, which handles toner resins, domestic demand declined, but overseas demand remained firm. As a result, sales were ¥3,960 million, up 1.7% year on year, and operating profit was ¥317 million, up 16.7%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, domestic sales of toner resins remained weak, while overseas sales remained strong. As a result, sales were ¥3,033 million, up 1.7% year on year, and operating profit was ¥263 million, up 14.8%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, demand declined in the Functional Materials field, including pressure-sensitive adhesives. In medical materials, sales of latex for raw materials remained firm, but diagnostic reagent sales remained weak. As a result, sales were ¥2,001 million, up 0.7% year on year, and operating profit was ¥183 million, up 37.7%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, sales of latex for in vitro diagnostic reagent raw materials remained strong. As a result, sales were ¥997 million, down 0.5% year on year, and operating profit was ¥103 million, up 70.9%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, sales in the Functional Materials field, which handles pressure-sensitive adhesives and other products, were broadly unchanged from the previous fiscal year. In the Chemical Products field, which handles toner resins, sales declined as demand for existing toner resins fell. In the medical materials field, sales increased as overseas sales of diagnostic reagents and sales of latex for raw materials remained firm. As a result, Chemical Products sales were slightly below the previous fiscal year. Overall, sales were ¥3,892 million, down 1.7% year on year, and operating profit was ¥271 million, up 6.5%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, demand in the medical materials field remained strong, but sales fell below the same quarter of the previous year, chiefly due to the significant impact of the decline in toner resin demand. As a result, sales were ¥2,983 million, down 2.0% year on year, and operating profit was ¥229 million, down 2.1%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, applications for pressure-sensitive adhesives expanded and the medical materials field performed well, but demand for toner resins declined, causing sales to fall below the same quarter of the previous year. As a result, sales were ¥1,986 million, down 2.1% year on year, and operating profit was ¥133 million, down 13.4%.」

「In the Chemical Products segment, which handles toner resins, resin bases such as “Acrybase” and medical materials, sales fell below the same quarter of the previous year, partly because demand for toner resins for overseas markets struggled to grow. As a result, sales were ¥1,002 million, down 1.2% year on year, and operating profit was ¥60 million, down 38.3%.」

「In the Chemical Products segment, which handles resin bases sold under the “Acrybase” brand, toner resins and medical materials, business remained strong, with sales of new pressure-sensitive adhesive products expanding steadily and sales exceeding those of the same quarter of the previous year. As a result, sales were ¥3,044 million, up 11.3% year on year, and operating profit was ¥234 million, up 26.8%.」

「In the Chemical Products segment, which handles resin bases sold under the “Acrybase” brand, toner resins and medical materials, business remained strong, including growth in pressure-sensitive adhesive sales. As a result, sales were ¥2,029 million, up 13.9% year on year, and operating profit was ¥153 million, up 88.3%.」

「In the Chemical Products segment, which handles resin bases sold under the “Acrybase” brand, toner resins and medical materials, sales increased as demand for pressure-sensitive adhesive bases among major users remained solid. As a result, sales were ¥1,015 million, up 15.9% year on year, and operating profit was ¥98 million, up 120.0%.」

「Although demand for toner resins declined, demand for resin bases, particularly for pressure-sensitive adhesives, remained solid, resulting in higher sales. As a result, sales were ¥3,681 million, up 3.1% year on year, and operating profit was ¥251 million, up 64.2%.」

「In the Chemical Products segment, which handles toner resins and resin bases such as “Acrybase,” demand in the pressure-sensitive adhesives field remained firm, but sales remained broadly flat year on year due in part to lower demand for toner resins. As a result, sales were ¥2,735 million, essentially unchanged year on year, and operating profit was ¥185 million, up 74.2%.」

「Although demand for toner resins struggled to grow, demand in the pressure-sensitive adhesives and medical materials fields increased, resulting in higher sales. As a result, sales were ¥1,781 million, up 1.1% year on year, and operating profit was ¥81 million, up 205.3%.」

「Development of in vitro diagnostic reagents, fine polymers for electronic components, and emulsion-based polymers for pressure-sensitive and other adhesives」